Health tech company Quix Labs recently opened its new City of London headquarters.
Located at 2 Puddle Dock, Blackfriars, the event on 2 August brought together pharmacy partners, GP and dental practices, investors, press and members of the Quix Labs team - marking a significant milestone in the company's journey.
The event included welcome remarks from Zach Starr, Founder and CEO of Quix Labs.
Founded in 2019, Quix Labs said it is on a mission to give smokers and vapers real choice - delivered through the most trusted and accessible part of the UK healthcare system: community pharmacy.
During the inauguration Zach Starr said: "From day one, we made a conscious decision to build alongside healthcare professionals rather than around them. This new headquarters is a symbol of that commitment - and a base from which we plan to grow significantly in the months and years ahead."
Quix Labs operates across four complementary brands:
Quixotic is an MHRA-notified, pharmacy-exclusive reusable device with four nicotine strengths down to zero.
Quitters Club is the company's digital support platform, helping users stay on track through guided support and community.
Quix Connect is a patient-facing platform connecting adults who smoke or vape to their nearest participating community pharmacy by postcode.
Quix for Pharmacy provides independent pharmacies with the tools, training and patient referral pathway to deliver a structured, private smoking and vaping support service.
The company also announced the launch of the Quix Clinical Council (QCC) - bringing together pharmacists, GPs, PCN leaders and other healthcare professionals to shape the future direction of the business.
